CD274 and cancer: We observed that the immune checkpoint inhibitor, PD-L1 (CD274), a ligand for T cell surface receptor PD-1, was expressed on the cancer cell surface of PW(+) and MA groups similar to the PW(−) group, compared to isotype control (p < 0.001, p < 0.01, or p < 0.01, respectively).